CN102671050A - 一种治疗肺脓肿的中药制剂 - Google Patents
一种治疗肺脓肿的中药制剂 Download PDFInfo
- Publication number
- CN102671050A CN102671050A CN2012101557456A CN201210155745A CN102671050A CN 102671050 A CN102671050 A CN 102671050A CN 2012101557456 A CN2012101557456 A CN 2012101557456A CN 201210155745 A CN201210155745 A CN 201210155745A CN 102671050 A CN102671050 A CN 102671050A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- semen
- medicine preparation
- parts
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000003453 lung abscess Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 210000000582 semen Anatomy 0.000 claims description 78
- 239000003814 drug Substances 0.000 claims description 38
- 241000628997 Flos Species 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- 229940023488 pill Drugs 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- -1 electuary Substances 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000801118 Lepidium Species 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 24
- 210000004072 lung Anatomy 0.000 description 23
- 206010062717 Increased upper airway secretion Diseases 0.000 description 19
- 208000026435 phlegm Diseases 0.000 description 19
- 206010036790 Productive cough Diseases 0.000 description 16
- 208000033809 Suppuration Diseases 0.000 description 16
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 208000024794 sputum Diseases 0.000 description 11
- 210000003802 sputum Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 239000012567 medical material Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 208000005946 Xerostomia Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000001174 ascending effect Effects 0.000 description 4
- 208000024753 bloody sputum Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 206010020741 Hyperpyrexia Diseases 0.000 description 3
- 206010061926 Purulence Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000723422 Catalpa Species 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027458 Metastases to lung Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010056349 Subdiaphragmatic abscess Diseases 0.000 description 1
- 208000003144 Subphrenic Abscess Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗肺脓肿的中药制剂,其以重量份计,包含以下组分:桔梗12-18,甘草7-11,浙贝母9-15,金银花12-18,薏苡仁28-32,葶苈子12-18,白及12-18,陈皮7-11,桃仁8-12,芦根28-32。相比于现有技术,本发明的中药针对肺脓肿内在病邪,辨症施治,疗效快,成本低,且无毒副作用,效果显著。
Description
技术领域
本发明涉及一种中药,更具体地说,涉及一种治疗肺脓肿的中药制剂。
背景技术
肺脓肿是由于多种病因所引起的肺组织化脓性病变。早期为化脓性炎症,继而坏死形成脓肿。临床以高热,咳嗽,咯大量脓性或臭味痰为特征。可分为原发性肺脓肿和继发性肺脓肿,前者多与吸入有关,好发于肺下叶背段及上叶后段,右侧比左侧更为常见,亦称吸入性肺脓肿;继发性肺脓肿以败血症引起的血液性肺脓肿较多见,也可来源于邻近脏器的直接侵入,如肝阿米巴或隔下脓肿可侵入肺部,引起肺脓肿。病程超过3个月,迁延不愈者为慢性肺脓肿。本病多发生于壮年,男性多于女性。肺脓肿早期须积极彻底治疗,一般预后良好。肺脓肿属中医“肺痈”范畴。对于肺脓肿的治疗,西医可采用抗生素,病情严重的则采用手术治疗,但长期使用抗生素会产生耐药性,危害较大。
发明内容
本发明的目的是提供一种治疗肺脓肿的中药制剂,其针对肺脓肿内在病邪,辨症施治,针对性强,疗效快,成本低,且无毒副作用,能达起到很好的治疗效果。
为了实现上述的目的,本发明采用以下技术方案:一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗12-18,甘草7-11,浙贝母9-15,金银花12-18,薏苡仁28-32,葶苈子12-18,白及12-18,陈皮7-11,桃仁8-12,芦根28-32。
本发明中药物的机理分析:
桔梗:味苦、辛,性微温。入肺经。宣肺、祛痰、利咽、排脓、利五脏。主治咳嗽痰多、咽喉肿痛、肺痈吐脓、胸满胁痛、痢疾腹痛、口舌生疮。《本草通玄》:桔梗之用,惟其上入肺经,肺为主气之脏,故能使诸气下降,世俗泥为上升之剂不能下行,失其用矣。
甘草:性平,味甘,归十二经。补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。
浙贝母:味苦,性寒。归肺,心经。清热化痰,降气止咳,散结消肿。用于风热或痰热咳嗽,肺痈吐脓,瘰疬瘿瘤,疮痈肿毒。《本草正》:大治肺痈肺萎,咳喘,吐血,衄血,最降痰气,善开郁结,止疼痛,消胀满,清肝火,阴耳目,除时气烦热,黄疸淋闭,便血溺血。
金银花:甘;寒。归肺;胃经。清热解毒,主治温病发热,热毒血痢,痈肿疔疮,喉痹及多种感染性疾病。《滇南本草》:清热,解诸疮,痈疽发背,丹流瘰疬。
薏苡仁:甘;淡;微寒。归脾;肺;肾经。利湿健脾;舒筋除痹;清热排脓。主治水肿,脚气,小便淋沥,湿温病,泄泻带下,风湿痹痛,筋脉拘挛,肺痈,肠痈,扁平疣。《药品化义》:薏米,味甘气和,清中浊品,能健脾阴,大益肠胃。
葶苈子:辛,苦,寒。归肺,心,肝,胃,膀胱经。泻肺降气;祛痰平喘;利水消肿;泄逐邪。用于痰涎壅肺之喘咳痰多;肺痈;水肿;胸腹积水;小便不利;慢性肺源性心脏病;心力衰竭之喘肿;瘰疬结核。《开宝本草》:疗肺壅上气咳嗽,定喘促,除胸中痰饮。
白及:苦;甘;涩;寒。归肺;胃经。收敛止血;消肿生肌。用于咯血,吐血,衄血,便血,外伤出血,痈疮肿毒,烫灼伤,手足皲裂,肛裂。《纲目》:白及,性涩而收,故能入肺止血,生肌治疮也。
陈皮:性温,味辛、味苦。入脾经、胃经、肺经。理气健脾,调中,燥湿,化痰。《日用本草》:能散能泻,能温能补,能消膈气,化痰涎,和脾止嗽,通五淋。
桃仁:苦、甘,平。归心、肝、大肠经。活血祛瘀,润肠通便,止咳平喘。用于经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。《用药心法》:桃仁,苦以泄滞血,甘以生新血,故凝血须用。又去血中之热。 芦根:甘;寒。归肺;胃;膀胱。清热生津;除烦止呕;利尿;透疹。用于热病烦渴,胃热呕吐,肺热咳嗽,肺痈吐脓,热淋,麻疹等。《玉楸药解》:清降肺胃,消荡郁烦,生津止渴,除呕下食,治噎哕懊憹。
针对溃脓期肺脓肿,中医认为血败肉腐,痈脓内溃外泄,故咯吐大量腥臭脓痰、血痰;脓毒蕴肺,肺气不利,肺脉瘀阻,而见胸中烦闷疼痛,气喘;肺络受损,故而咳痰带血;热毒内蒸,热耗津液,故身热面赤,口渴喜饮;舌红,苔黄腻,脉滑数为毒热内蕴之征象。
方中之选者,清热解毒,化痰排脓,桔梗宣肺排脓,甘草清热解毒、祛痰止咳,浙贝母清热化痰、降气止咳、散结消肿,用于痰热咳嗽、肺痈吐脓,金银花清热解毒,薏苡仁清热排脓,葶苈子泻肺降气、祛痰平喘,白及收敛止血,陈皮燥湿化痰,桃仁活血祛瘀、止咳平喘,芦根清热生津,用于肺热咳嗽、肺痈吐脓。针对成痈期肺脓肿疗效确切,治疗效果显著,无副作用。
另外,以重量份计,本发明的中药制剂还可以包含皂角刺9-15,以针对咳痰脓出不畅者,化痰排脓。
另外,以重量份计,本发明的中药制剂还可以包含黄芪28-32,以针对无力咳痰者,益气扶正,托毒排脓。
另外,以重量份计,本发明的中药制剂还可以包含藕节7-11,丹皮9-15,白茅根28-32,三七2-4,以针对咳血量多者,增强凉血止血。
本发明的中药剂型可以采用片剂、颗粒剂、丸剂、胶囊剂、溶液剂、口服液、口含片、颗粒剂、冲剂、散剂、混悬剂、粉剂。优选地,可以采用溶液剂、颗粒剂、丸剂和胶囊剂。
使用效果
对50名肺脓肿患者(年龄20-50)使用本发明的治疗肺脓肿的中药,持续治疗1个疗程(半个月),其中23例完全治愈;23例症状缓解;无效4例,总体有效率达92%,且无复发。
实例:
患者1:钟某,男性,29岁,流感后期出现恶寒发热、咳嗽咯痰、痰脓量多、气急、高热、胸痛、口干、舌红等症状。使用本发明的中药制剂进行治疗,1周后发热、脓痰、高热、胸痛症状明显减轻,但仍有轻微咳嗽、口干。后继续用药1周,上述症状完全消失,恢复健康,无复发。
患者2:赵某,男性,42岁,咳嗽、痰多呈黏液脓性痰、痰中带血丝、胸痛、发热、口干。前期抗生素治疗,效果不显著,后服用本发明的中药制剂,血痰、胸痛症状在治疗3天后好转,继续服药1周后,口干、发热症状消退,咳嗽症状减轻,痰液转为非脓性,痰量减少,继续服用中药1周后,上述症状完全消失,患者恢复健康,无复发。
患者3:朱某,女性,23岁,感冒后期出现咳嗽咯痰、痰脓性、血痰、痰量多,胸痛、发热等症状。症状持续1周有余,后服用本发明的中药制剂,治疗1周后病情好转,脓痰、血痰减轻,高热消退,痰液减少,痰液逐渐转为非脓性痰,继续服用中药1周后,上述症状完全消失,患者恢复健康,无复发。
具体实施方式
为了更好地理解本发明,下面通过实施例来描述本发明。
实施例1
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗12,甘草7,浙贝母9,金银花12,薏苡仁28,葶苈子12,白及12,陈皮7,桃仁8,芦根28。
其制备方法为:
以重量份计,取桔梗12,甘草7,浙贝母9,金银花12,薏苡仁28,葶苈子12,白及12,陈皮7,桃仁8,芦根28;将上述中药洗净,去杂质,放入容器加水没过药材浸泡,30分钟后,大火煎煮至沸腾,然后文火慢熬1小时;将药汁滤出,分袋包装,一袋200ml,早晚各服一袋。
实施例2
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗18,甘草11,浙贝母15,金银花18,薏苡仁32,葶苈子18,白及18,陈皮11,桃仁12,芦根32。
其制备方法为:
以重量份计,取桔梗18,甘草11,浙贝母15,金银花18,薏苡仁32,葶苈子18,白及18,陈皮11,桃仁12,芦根32;洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;颗粒分装机分装,即得颗粒剂。
实施例3
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30。
其制备方法为:
以重量份计,取桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30;洗净,干燥,将上述药材混合,用粉碎机粉碎为150-180目细粉,加入适当蜂蜜混合,制丸机制丸,低温干燥,分装,即得丸剂。
实施例4
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30。
其制备方法为:
以重量份计,取桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30;洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;将颗粒用胶囊填充剂制成0.4g/粒胶囊。
实施例5
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,皂角刺12。
其制备方法为:
以重量份计,取桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,皂角刺12;洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;将颗粒用胶囊填充剂制成0.4g/粒胶囊。
实施例6
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,黄芪30。
其制备方法为:
以重量份计,取桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,黄芪30;洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;将颗粒用胶囊填充剂制成0.4g/粒胶囊。
实施例7
一种治疗肺脓肿的中药制剂,以重量份计,包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,藕节9,丹皮12,白茅根30,三七3。
其制备方法为:
以重量份计,取桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30,藕节9,丹皮12,白茅根30,三七3;洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;将颗粒用胶囊填充剂制成0.4g/粒胶囊。
Claims (7)
1.一种治疗肺脓肿的中药制剂,其特征在于,以重量份计,包含以下组分:桔梗12-18,甘草7-11,浙贝母9-15,金银花12-18,薏苡仁28-32,葶苈子12-18,白及12-18,陈皮7-11,桃仁8-12,芦根28-32。
2.根据权利要求1所述的中药制剂,其特征在于,以重量份计,优选包含以下组分:桔梗15,甘草9,浙贝母12,金银花15,薏苡仁30,葶苈子15,白及15,陈皮9,桃仁10,芦根30。
3.根据权利要求1所述的中药制剂,其特征在于,以重量份计,还包含皂角刺9-15。
4.根据权利要求1所述的中药制剂,其特征在于,以重量份计,还包含黄芪28-32。
5.根据权利要求1所述的中药制剂,其特征在于,以重量份计,还包含藕节7-11,丹皮9-15,白茅根28-32,三七2-4。
6.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂采用片剂、颗粒剂、丸剂、胶囊剂、溶液剂、口服液、口含片、颗粒剂、冲剂、散剂、混悬剂、粉剂。
7.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂优选采用溶液剂、颗粒剂、丸剂和胶囊剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101557456A CN102671050A (zh) | 2012-05-19 | 2012-05-19 | 一种治疗肺脓肿的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101557456A CN102671050A (zh) | 2012-05-19 | 2012-05-19 | 一种治疗肺脓肿的中药制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102671050A true CN102671050A (zh) | 2012-09-19 |
Family
ID=46804034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101557456A Pending CN102671050A (zh) | 2012-05-19 | 2012-05-19 | 一种治疗肺脓肿的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102671050A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383277A (zh) * | 2014-10-27 | 2015-03-04 | 青岛祥翔生物医药科技有限公司 | 一种治疗成痈期肺痈病的中药 |
| CN104587298A (zh) * | 2015-01-17 | 2015-05-06 | 王动力 | 一种治疗肺痈的中药组合物 |
| CN104815317A (zh) * | 2015-05-25 | 2015-08-05 | 高树霞 | 一种治疗肺脓肿的中药制剂 |
| CN104857493A (zh) * | 2015-06-11 | 2015-08-26 | 王淑霞 | 一种治疗肺脓疡的中药组合物 |
| CN105435139A (zh) * | 2014-08-31 | 2016-03-30 | 王宁 | 治疗肺脓肿的中药 |
| CN105943871A (zh) * | 2016-07-11 | 2016-09-21 | 王希法 | 一种用于治疗肺脓肿的中药制剂及制备方法 |
| CN111743980A (zh) * | 2020-08-10 | 2020-10-09 | 廖贵恢 | 一种芦根肺痈汤及其制备方法 |
| CN113975357A (zh) * | 2021-12-27 | 2022-01-28 | 广东益可维生物技术有限公司 | 清肺化痰、消痈排脓、清热利湿的中药组合物及其应用 |
-
2012
- 2012-05-19 CN CN2012101557456A patent/CN102671050A/zh active Pending
Non-Patent Citations (1)
| Title |
|---|
| 医通无忧网: "《医通无忧网》", 17 November 2011, HTTP://WWW.51ETONG.COM/S/JKBJ/19191.SHTML * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435139A (zh) * | 2014-08-31 | 2016-03-30 | 王宁 | 治疗肺脓肿的中药 |
| CN104383277A (zh) * | 2014-10-27 | 2015-03-04 | 青岛祥翔生物医药科技有限公司 | 一种治疗成痈期肺痈病的中药 |
| CN104587298A (zh) * | 2015-01-17 | 2015-05-06 | 王动力 | 一种治疗肺痈的中药组合物 |
| CN104815317A (zh) * | 2015-05-25 | 2015-08-05 | 高树霞 | 一种治疗肺脓肿的中药制剂 |
| CN104857493A (zh) * | 2015-06-11 | 2015-08-26 | 王淑霞 | 一种治疗肺脓疡的中药组合物 |
| CN105943871A (zh) * | 2016-07-11 | 2016-09-21 | 王希法 | 一种用于治疗肺脓肿的中药制剂及制备方法 |
| CN111743980A (zh) * | 2020-08-10 | 2020-10-09 | 廖贵恢 | 一种芦根肺痈汤及其制备方法 |
| CN113975357A (zh) * | 2021-12-27 | 2022-01-28 | 广东益可维生物技术有限公司 | 清肺化痰、消痈排脓、清热利湿的中药组合物及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102671050A (zh) | 一种治疗肺脓肿的中药制剂 | |
| CN107875255B (zh) | 一种润肠通便、减肥的组合物 | |
| CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
| CN104173937A (zh) | 一种疏肝利胆的中药组合物及其应用 | |
| CN102671049A (zh) | 一种治疗肺脓肿的中药组合物 | |
| CN103142949A (zh) | 一种治疗小儿哮喘的中成药 | |
| CN104940784A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN102961643A (zh) | 一种治疗支气管扩张症的中药制剂 | |
| CN103638361B (zh) | 一种治疗咳嗽的药物及其制备方法 | |
| CN103263632A (zh) | 一种治疗痰结型梅核气的中药配方 | |
| CN104107363A (zh) | 一种治疗肝经湿热型外阴湿疹的中药组合物 | |
| CN104306929A (zh) | 一种治疗重症急性胰腺炎的中药配方及其制备方法 | |
| CN104523873A (zh) | 一种治疗痛风的药物组合物 | |
| CN102671023A (zh) | 一种治疗肺脓肿的中成药 | |
| CN102670896A (zh) | 一种治疗细菌性痢疾的中成药 | |
| CN103285147A (zh) | 一种治疗肺肾阴虚型经行吐衄的中药组合物 | |
| CN103212026A (zh) | 一种治疗胆石症的中药及其制备方法和服用方法 | |
| CN104027760A (zh) | 一种治疗风痰伏肺证型哮喘的中药 | |
| CN103263618A (zh) | 一种治疗肾结核的中药制剂 | |
| CN103071073A (zh) | 一种治疗流行性腮腺炎的中成药 | |
| CN102961627A (zh) | 一种治疗支气管扩张症的中药配方 | |
| CN102961628A (zh) | 一种治疗支气管扩张症的中成药 | |
| CN102670897A (zh) | 一种治疗细菌性痢疾的中药制剂 | |
| CN102580032A (zh) | 具有促排石作用的中药组合物片剂、散剂、口服液及制备方法 | |
| CN104107291A (zh) | 一种治疗痰火郁肺型毛细支气管炎的中药配方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120919 |